Recombinant Human IL-7 Protein

A DNA sequence encoding the Human IL-7 protein (P13232) (1-177) was expressed with a polyhistidine tag at the C-terminus.

Introducing the Recombinant Human IL-7 Protein, a cutting-edge biotechnological advancement in the field of immunology. This highly purified and bioactive protein is meticulously engineered to exhibit exceptional potency and efficacy, making it an indispensable tool for researchers and scientists alike.

The Recombinant Human IL-7 Protein is produced through a state-of-the-art recombinant DNA technology, ensuring the utmost purity and consistency in every batch. This protein is derived from a human source, making it highly compatible with human biological systems, thereby minimizing any potential adverse effects.

With its remarkable ability to stimulate the proliferation and differentiation of T cells, the Recombinant Human IL-7 Protein plays a pivotal role in enhancing immune responses. By binding to the IL-7 receptor, this protein activates critical signaling pathways, leading to the expansion and activation of T cells. This unique mechanism of action makes it an invaluable tool for studying immune system development, immune cell homeostasis, and immune-related diseases.

The Recombinant Human IL-7 Protein is supplied in a lyophilized form, ensuring long-term stability and ease of storage. Each vial contains a precisely measured amount of protein, allowing for accurate and reproducible experiments. Furthermore, this protein can be easily reconstituted in a variety of buffers, providing flexibility and convenience for researchers.

In addition to its research applications, the Recombinant Human IL-7 Protein holds great promise in the development of novel immunotherapies. Its ability to enhance T cell responses makes it an attractive candidate for the treatment of various diseases, including cancer and autoimmune disorders. Ongoing clinical trials are exploring the therapeutic potential of this protein, further highlighting its significance in the medical field.

In conclusion, the Recombinant Human IL-7 Protein represents a groundbreaking advancement in immunological research and therapeutic development. Its exceptional potency, purity, and versatility make it an indispensable tool for scientists and a beacon of hope for patients worldwide.